LANNETT REPORTS FISCAL 2022 THIRD-QUARTER FINANCIAL RESULTS
/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2022 third quarter ended March 31, 2022....
Stay updated with breaking news from Tim Crew. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2022 third quarter ended March 31, 2022....
/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has initiated the pivotal clinical trial of biosimilar insulin glargine, a product...
/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into material definitive agreements to sell its liquid drug manufacturing...
/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2022 second quarter ended December 31, 2021. "For the...
/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2022 second quarter ended December 31, 2021. "For the...